Evidence map›Paper›PMID 42111300›Full record

ReviewBrain circulation

A narrative review of neuroprotective effects of albumin: The underlying mechanisms and therapeutic prospects in ischemic stroke.

Zhihong Xu, Yuchao Dou, Sihu Pan, Ming Wei

Abstract readReview
In one paragraph

Review in Brain circulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhihong XuSchool of Medicine, Tianjin University, Tianjin, China.
Yuchao DouDepartment of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Sihu PanDepartment of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Ming WeiClinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Albumin, the most prevalent protein in human plasma, has demonstrated neuroprotective properties in preclinical studies. However, its efficacy in clinical trials remains controversial. We summarized the neuroprotective mechanisms of albumin and analyzed the possible reasons behind this controversy. Furthermore, hypoalbuminemia has strong predictive effects, which have always been overlooked. Therefore, we summarized the predictive effects of hypoalbuminemia and highlighted its importance. Finally, brain no-reflow and glymphatic system are the two factors influencing the prognosis of patients with acute ischemic stroke. We investigated the relationship between albumin and these factors, proposing possible mechanisms for the neuroprotective effects of albumin.

Indexed as

Acute ischemic strokealbuminglymphatic systemno-reflow

Identifiers

PMID42111300
PMCPMC13152233

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.